A
Arthur K. Shapiro
Researcher at Icahn School of Medicine at Mount Sinai
Publications - 45
Citations - 3191
Arthur K. Shapiro is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Tourette syndrome & Tics. The author has an hindex of 30, co-authored 45 publications receiving 3151 citations.
Papers
More filters
Journal ArticleDOI
The Hopkins Symptom Checklist (HSCL): Factors derived from the HSCL-90
TL;DR: A factor analysis of the 90-item version of the Hopkins Symptom Checklist, performed on the pretreatment self-ratings of nonpsychotic outpatients with symptoms of depression and anxiety, revealed the presence of 8 clinically meaningful factors.
Journal ArticleDOI
Controlled Study of Haloperidol, Pimozide, and Placebo for the Treatment of Gilles de la Tourette's Syndrome
Elaine Shapiro,Arthur K. Shapiro,George Fulop,Michael L. Hubbard,John Mandeli,Johanna Nordlie,Robert A. Phillips +6 more
TL;DR: The results of this controlled study of the treatment of 57 patients with Gilles de la Tourette's syndrome suggested that both haloperidol and pimozide were more effective than placebo, but that hal operidol was slightly moreeffective than pimozides.
Book
The Powerful Placebo: From Ancient Priest to Modern Physician
Arthur K. Shapiro,Elaine Shapiro +1 more
TL;DR: A comprehensive and scholarly examination of the placebo effect can be found in this paper, where the authors survey the use of placebos from antiquity to modern times and examine the development, use and validity of the double-blind controlled clinical trial.
Journal ArticleDOI
Dream reporting following abrupt and gradual awakenings from different types of sleep.
Journal ArticleDOI
Gilles de la Tourette's syndrome: clinical, genetic, psychologic, and biochemical aspects in 21 selected families.
TL;DR: Patients and relatives with Tourette's syndrome, members of 21 selected families, participated in a 1-day clinic, and no evidence of abnormality was found in plasma dopamine beta hydroxylase, or norepinephrine levels.